Logo-bi
Original Research
Keyvan Yousefi, Fatemeh Fathiazad, Hamid Soraya, Maryam Rameshrad, Nasrin Maleki-Dizaji, Alireza Garjani*
Bioimpacts. 2014;4(1): 21-27. doi: 10.5681/bi.2014.001
PMCID: PMC4005279     PMID: 24790895     Scopus ID: 84900492052    
PDF
XML
Cited By:
Original Research
Amna Parveen, Muhammad Sajid Hamid Akash*, Kanwal Rehman, Qaisar Mehmood, Muhammad Imran Qadir*
Bioimpacts. 2014;4(1): 43-48. doi: 10.5681/bi.2014.013
PMCID: PMC4005283     PMID: 24790898     Scopus ID: 84900490170    
PDF
XML
Cited By:
Original Research
Phraepakaporn Kunnaja*, Somsakul Pop Wongpalee, Ampai Panthong
Bioimpacts. 2014;4(4): 183-189. doi: 10.15171/bi.2014.018
PMCID: PMC4298709     PMID: 25671174     Scopus ID: 84920948513    
PDF
XML
Cited By:
Original Research
Fahsai Kantawong*, Supawatchara Singhatong, Aomjai Aomjai, Kantarose Boonyuen, Niroot Mooti, Phenphichar Wanachantararak, Thasaneeya Kuboki
Bioimpacts. 2017;7(1): 13-23. doi: 10.15171/bi.2017.03
PMCID: PMC5439385     PMID: 28546949     Scopus ID: 85019158241    
Spotlight
Danial Mehranfard ORCID, Robert C. Speth* ORCID
BioImpacts. 2022;12(2): 171-174. doi: 10.34172/bi.2022.23980
PMCID: PMC8905591     PMID: 35411295     Scopus ID: 85127141535    
This spotlight briefly describes the CAP and its potential role as a therapeutic target for the treatment of COVID-19 infections using vagus nerve stimulation or selective alpha7 nicotinic acetylcholine receptor agonists.


As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate: 24% 
Publication fee: Free of charge